Rein Therapeutics Inc. Common Stock (RNTX)
Stock · NASDAQ · Health Care
$0.5884as of 10/16/2026
Price chart
Active signals
RNTX Signal Track Record
How signals performed across all stocks →What RNTX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 52 | -8.2% | 33% | October 1, 2026 |
| Bollinger Band Breakout | 23 | -7.2% | 26% | September 4, 2026 |
| Bollinger Band BreakdownActive now | 19 | -8.2% | 37% | September 15, 2026 |
| 200-Day Moving Average TouchActive now | 5 | -11.8% | 40% | March 16, 2026 |
| Any 20-session window (baseline) | -4.0% | 43% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About RNTX
Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate is LTI-03, a peptide, which is in Phase 2 clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). It also offers LTI-01, a proenzyme that has completed Phase 1b and Phase 2a clinical…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 10
- Website
- www.reintx.com/
Fundamentals
- 1-day range
- $0.57$0.6219
- Market cap
- $67.45M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-1.59
- Dividend yield
- —
- Beta
- 1.40
- Avg. volume
- 453.4K
Forecasts
2 analyst ratings
Rein Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- RNTXRein Therapeutics Inc. Common Stock$0.59▼ 6.05%Market cap $67.45MP/E —$0.5401$2.18
- MNOVMedicinova Inc Common Stock$1.42▼ 2.07%Market cap $66.94MP/E —$1.17$3.9
- CINGCingulate Inc. Common Stock$4.36▼ 0.68%Market cap $68.02MP/E —$3.16$11.89
- CLNNClene Inc. Common Stock$3.1▼ 6.34%Market cap $68.24MP/E —$3.24$13.5
- IBIOiBio Inc. Common Stock$0.77▼ 1.28%Market cap $69.05MP/E —$0.7328$3.82
- XBITXBiotech Inc. Common Stock$2.12▼ 1.85%Market cap $69.51MP/E —$2.09$3.44
- INOInovio Pharmaceuticals Inc. Common Stock$0.99▼ 4.81%Market cap $69.62MP/E —$0.5632$2.72
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| RNTX Rein Therapeutics Inc. Common Stock | $67.45M | — | $0.59 | ▼ 6.05% | $0.5401$2.18 |
| MNOV Medicinova Inc Common Stock | $66.94M | — | $1.42 | ▼ 2.07% | $1.17$3.9 |
| CING Cingulate Inc. Common Stock | $68.02M | — | $4.36 | ▼ 0.68% | $3.16$11.89 |
| CLNN Clene Inc. Common Stock | $68.24M | — | $3.1 | ▼ 6.34% | $3.24$13.5 |
| IBIO iBio Inc. Common Stock | $69.05M | — | $0.77 | ▼ 1.28% | $0.7328$3.82 |
| XBIT XBiotech Inc. Common Stock | $69.51M | — | $2.12 | ▼ 1.85% | $2.09$3.44 |
| INO Inovio Pharmaceuticals Inc. Common Stock | $69.62M | — | $0.99 | ▼ 4.81% | $0.5632$2.72 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- VON RICKENBACH JOSEF H · May 27, 2026 · Buy4.5K @ $1.07
- VON RICKENBACH JOSEF H · May 26, 2026 · Buy23.2K @ $1.06
- VON RICKENBACH JOSEF H · May 22, 2026 · Buy15.9K @ $1.05
- VON RICKENBACH JOSEF H · May 21, 2026 · Buy3.4K @ $1.04
- WINDSOR JAMES BRIAN · May 8, 2026 · Grant150.0K
- WINDSOR JAMES BRIAN · April 30, 2026 · Buy25.0K @ $1
Institutional Ownership
March 31, 2026
- Total shares held
- 11.21M
- Total value held
- $14.56M
- Institutional holders
- 43
- Unknown4.39M
- Unknown1.98M
- Unknown998.5K
- Unknown511.6K
- Unknown420.0K
- Unknown411.6K
- Unknown348.7K
- Unknown344.7K
- Unknown273.6K
- Unknown239.5K
See the full, filterable feed with live charts on the MarketWall dashboard.